Scientific Online Resource System

International Bulletin of Otorhinolaryngology

Historical origin and meaning of the term „glial tumor“

E. Moynova, Y. Enchev, M. Moynov, G. Stoyanov, B. Iliev, T. Kondev, S. Marianova, A. Demirci

Abstract

In everyday neurosurgical practice, the term „glial tumor“ is associated with astrocytomas, glioblastomas, and oligodendrogliomas, although historically this has not always been the case. The term „glial tumor“ was first given by Virchow in the 19th century as a term initially combining all primary brain tumors under this name. It derives from the name of the group of „supporting“ nerve cells - glia or neuroglia (from the Greek glia - glue), a group which for many years was wrongly ascribed only a cohesive or supporting function.
In 1926, in their classification of glial tumors - A Classification of the Tumors of the Glioma Group on a Histogenetic Basis with a Correlated Study of Prognosis, one of the founding fathers of neuropathology Percival Bailey and the founding father of modern neurosurgery – Harvey Cushing ascribed several different tumors in this group: in addition to neuroepithelioma, spongioblastoma multiforme, astrocytoma and ependymoma, they also add medulloblastoma, astroblastoma, oligodendroglioma and unipolar spongioblastoma. Since then, the classification of glial tumors has undergone many changes to its current form. In the latest classification of brain tumors published in 2021, glial tumors are united in a common group together with glioneuronal and neuronal tumors. Their extensive group includes tumors with different prognosis, age presentation, molecular profile and therapeutic response. From a neurosurgical point of view, the term „glial tumor“ does not carry a prognostic value, but only determines the belonging of the tumor to the astrocyte, oligodendrocyte cell line or their precursor cells. In relation to that an interesting question arises- why the remaining tumors originating from glial cells other than astrocytic, such as ependymomas, lost their belonging to the group of glial tumors, or such as intracranial schwannomas, are not included in it at all.

Full Text


References

Scherer HJ. A CRITICAL REVIEW THE PATHOLOGY OF CEREBRAL GLIOMAS. http://jnnp.bmj.com/

Virchow R. Die Krankhaften Geschwülste. Vol 3 volumes.; 1863.

Wilkins RH, Rengachary SS. Neurosurgery. Vol 3-Volume. (Rengachary SS, Wilkins RH, eds.).; 1995.

Къркиселян Р. Неврохирургия. 2000;Том V,.

J M Byers 3rd. Rudolf Virchow-father of cellular pathology. Am J Clin Pathol . Published online October 1989:2-8.

Louis DN, Ohgaki H, Wiestier OD, et al. WHO Classification of Tumours of the Central Nervous System.

Ferguson S, Lesniak MS. Percival Bailey and the classification of brain tumors. Neurosurg Focus . 2005;18(4):1-6.

Penfield W, Montreal C. THE CLASSIFICATION OF GLIOMAS AND NEUROGLIA CELL TYPES. http://archneurpsyc.jamanetwork.com/

Martin-Villalba A, Okuducu AF, von Deimling A. The evolution of our understanding on glioma. Brain Pathology. 2008;18(3):455-463. doi:10.1111/j.1750-3639.2008.00136.x

Stoyanov G S PL, Dzhenkov D L. Hans Joachim Scherer and His Impact on the Diagnostic. Cureus. 2019;11(11). doi:10.7759/cureus.6148

Thurnher MM. 2007 World Health Organization classification of tumours of the central nervous system. Cancer Imaging. 2009;9(SPEC. ISS. A). doi:10.1102/1470-7330.2009.9001

Louis DN, Perry A, Wesseling P, et al. The 2021 WHO Classification of Tumors of the Central Nervous System: asummary. Neuro Oncol. 2021;23(8):1231-1251. doi:10.1093/neuonc/noab106

Shirahata M, Ono T, Stichel D, et al. Novel, improved grading system(S) for IDH-mutant astrocytic gliomas. Acta Neuropathol. 2018;136(1):153-166. doi:10.1007/s00401-018-1849-4

von Deimling A, Ono T, Shirahata M, Louis DN. Grading of Diffuse Astrocytic Gliomas: A Review of Studies before and after the Advent of IDH Testing. Semin Neurol. 2018;38(1):19-23. doi:10.1055/s-0038-1636430




DOI: http://dx.doi.org/10.14748/orl.v18i2.8768

Refbacks

Font Size


|